This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES: Oligonucleotide & Peptide Therapeutics Content Hub
24/7 Access
Digital & In-Person
Menu

Content Contributors

Intertek

Contact

www.intertek.com/pharmaceutical

We're bringing you

  • CASE STUDY: CMC Considerations for mRNA Based Therapeutics - Analytical Approaches to Characterize Capital Quality Attributes

    On Demand - For Members
    View Session

  • SPECIAL REPORT: Peptide Therapeutics - Designing a Science-Led Strategic Quality Control Program

    On Demand - For Members
    View Session

Our Content Contributors

Meet Intertek

And other industry leaders at TIDES: Oligonucleotide & Peptide Therapeutics Content Hub

View Agenda